Genedx Holdings Corp (WGS)

$123.95 -1.94 (-1.54%)
Market Cap 3.56B
Revenue (ttm) 305.45M
Net Income (ttm) -52.29M
EPS (ttm) N/A
PE Ratio 82.82
Forward PE 104.04
Profit Margin -17.12%
Debt to Equity Ratio 0.19
Volume 311,900
Avg Vol 785,164
Day's Range N/A - N/A
Shares Out 28.73M
Stochastic %K 22%
Beta 2.04
Analysts Strong Sell
Price Target $113.41

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. The company is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
resurrect_momo21
resurrect_momo21 Sep. 13 at 3:06 PM
$COCP $WGS 🤡called GeneDx a crime for yrs BUT reality smacks him in the fake "black face" 😂 $1.50 - $132+++ 20m to $4 billion in mcap. Same thing he says about cocrystal but in 6 months this turns to billions like WGS
0 · Reply
resurrect_momo21
resurrect_momo21 Sep. 12 at 8:36 PM
$COCP reload zone down here as pre market gave that chance to make 100%+ but now it's going to billions in cap after phase 1b and 2a in 6 months or less like $WGS or $CDTX
1 · Reply
resurrect_momo21
resurrect_momo21 Sep. 12 at 5:13 PM
$COCP $WGS this clown @Resurrected_Magic used to be the #1 bash frost lover check is old account and new one what a real psych-O 🤡 who got wiped out 5 yrs ago @the_original_magic removed for fraud by ST @Resurrected_Magic
0 · Reply
MaverikIT
MaverikIT Sep. 11 at 10:22 PM
$WGS - trash they saying 🤣🤣🤣 $NUTX
0 · Reply
DARKP00L
DARKP00L Sep. 11 at 2:11 PM
$WGS 10:07 on Sep. 11 2025 Piper Sandler Maintains Overweight on GeneDx Holdings, Raises Price Target to $140 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Sep. 11 at 2:08 PM
Piper Sandler updates rating for GeneDx Holdings ( $WGS ) to Overweight, target set at 120 → 140.
0 · Reply
dogDazeSummer
dogDazeSummer Sep. 9 at 2:43 PM
Only 5 new adds for RA in latest Q: $HNGE $JBIO $TNGX $WGS and a “pipeline in pill” company from Germany, forgot the name. Total holdings are 63 many making ATH today. Interesting focus on immune dermatology. Here’s how much cash he dropped into each new starter position: Might want to follow these 5 names. $15M into Hinge $9.9m into Jade $7.3m into Omada $5.4m into GeneDx $3.2k into Inflarx
1 · Reply
Halo202
Halo202 Sep. 8 at 9:32 PM
$WGS $132+ by Friday
0 · Reply
Fujitsu99
Fujitsu99 Sep. 8 at 7:25 PM
$WGS Didn’t pull back like I thought it might. Just sideways, which is what we want. Didn’t sell a single share.
0 · Reply
resurrect_momo21
resurrect_momo21 Sep. 7 at 4:08 PM
$COCP $WGS "aka john jones" obvs got wiped out in mkt big time still calls everything a "scam" get this 🤡called GeneDx a fraud for yrs BUT reality smacks him in the fake "black face" 😂 $1.50 - $132+++ 20 mill to $4 billion in mkt cap. Same thing he says about cocrystal but just watch what happens on this one too biscayne boys 4ever❤️!! @the_original_magic 8200 meltdown bash posts @Resurrected_Magic 5600 bash posts
0 · Reply
Latest News on WGS
GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 10:45 AM EDT - 6 days ago

GeneDx Holdings Corp. (WGS) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Seer Appoints Isaac Ro to its Board of Directors

Sep 2, 2025, 7:00 AM EDT - 12 days ago

Seer Appoints Isaac Ro to its Board of Directors

SEER

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

Aug 6, 2025, 9:30 AM EDT - 5 weeks ago

Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS)

GeneDx to Participate in Upcoming Investor Conferences

Aug 6, 2025, 8:30 AM EDT - 5 weeks ago

GeneDx to Participate in Upcoming Investor Conferences

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

Jul 31, 2025, 10:22 AM EDT - 6 weeks ago

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

Jul 31, 2025, 3:30 AM EDT - 6 weeks ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

Jul 30, 2025, 5:07 PM EDT - 6 weeks ago

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

Jul 30, 2025, 8:38 AM EDT - 6 weeks ago

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

Jul 29, 2025, 5:06 PM EDT - 6 weeks ago

GeneDx Holdings Corp. (WGS) Q2 2025 Earnings Call Transcript

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights

Jul 29, 2025, 6:30 AM EDT - 6 weeks ago

GeneDx Reports Second Quarter 2025 Financial Results and Business Highlights

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

Jul 28, 2025, 9:43 AM EDT - 6 weeks ago

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Fraud Investigation with the Schall Law Firm

GeneDx: Strong Testing Volume And An Invaluable Genomic Database

Jul 15, 2025, 2:52 AM EDT - 2 months ago

GeneDx: Strong Testing Volume And An Invaluable Genomic Database

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

Jul 10, 2025, 8:30 AM EDT - 2 months ago

GeneDx to Report Second Quarter 2025 Financial Results on Tuesday, July 29, 2025

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

Jun 25, 2025, 8:30 AM EDT - 2 months ago

GeneDx Announces Publication of SeqFirst Study Demonstrating Need for First Tier Rapid Genomic Testing for Non-Critical Care Pediatric Inpatients in The Journal of Pediatrics

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

Jun 23, 2025, 3:17 PM EDT - 2 months ago

GeneDx Announces American Academy of Pediatrics Recommends Exome and Genome Sequencing as First-Tier Tests for Children with Global Developmental Delay or Intellectual Disability

GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

May 22, 2025, 8:00 AM EDT - 4 months ago

GeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at Scale

GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip

May 20, 2025, 5:21 AM EDT - 4 months ago

GeneDx: Strong Fundamentals Intact As Market Misreads Test Volume Dip

GeneDx: Time To Buy The Dip

May 14, 2025, 5:35 AM EDT - 4 months ago

GeneDx: Time To Buy The Dip

GeneDx Announces Completion of Fabric Genomics Acquisition

May 7, 2025, 8:30 AM EDT - 4 months ago

GeneDx Announces Completion of Fabric Genomics Acquisition

GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 1:15 PM EDT - 4 months ago

GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

Apr 30, 2025, 6:30 AM EDT - 4 months ago

GeneDx Reports First Quarter 2025 Financial Results and Business Highlights

GeneDx: Strengthening Leadership In Genomic Diagnostics

Apr 28, 2025, 11:13 AM EDT - 4 months ago

GeneDx: Strengthening Leadership In Genomic Diagnostics

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

Apr 16, 2025, 6:00 AM EDT - 5 months ago

GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

Apr 8, 2025, 8:05 AM EDT - 5 months ago

GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

Apr 3, 2025, 8:00 AM EDT - 5 months ago

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 20, 2025, 4:05 PM EDT - 6 months ago

GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

Mar 18, 2025, 7:05 AM EDT - 6 months ago

Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

Mar 13, 2025, 8:30 AM EDT - 6 months ago

GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

Mar 13, 2025, 8:30 AM EDT - 6 months ago

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich

Mar 12, 2025, 1:13 PM EDT - 6 months ago

GeneDx Holdings: There Is Upside Potential, But Price Tag Is Rich

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

Mar 4, 2025, 8:30 AM EST - 6 months ago

GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Connect

Feb 25, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Connect

Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols

Feb 24, 2025, 11:00 AM EST - 7 months ago

Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out

Feb 24, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against GeneDx Holdings Corp. (WGS) And Encourages Shareholders to Reach Out

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation

Feb 23, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GeneDx Holdings Corp. (WGS) and Encourages Shareholders to Learn More About the Investigation

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 21, 2025, 10:00 AM EST - 7 months ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 20, 2025, 10:00 AM EST - 7 months ago

GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect

Feb 19, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Investors to Connect

Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy'

Feb 19, 2025, 9:29 AM EST - 7 months ago

Reviewing GeneDx Holdings: Exome Testing And EPIC Aura Integration Make It A GARP 'Buy'

GeneDx CEO on pediatric genetic testing, future of genome sequencing and share surge

Feb 18, 2025, 3:54 PM EST - 7 months ago

GeneDx CEO on pediatric genetic testing, future of genome sequencing and share surge

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript

Feb 18, 2025, 11:02 AM EST - 7 months ago

GeneDx Holdings Corp. (WGS) Q4 2024 Earnings Call Transcript

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Stockholders to Inquire about Securities Investigation

Feb 18, 2025, 10:00 AM EST - 7 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Stockholders to Inquire about Securities Investigation

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

Feb 18, 2025, 6:00 AM EST - 7 months ago

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

resurrect_momo21
resurrect_momo21 Sep. 13 at 3:06 PM
$COCP $WGS 🤡called GeneDx a crime for yrs BUT reality smacks him in the fake "black face" 😂 $1.50 - $132+++ 20m to $4 billion in mcap. Same thing he says about cocrystal but in 6 months this turns to billions like WGS
0 · Reply
resurrect_momo21
resurrect_momo21 Sep. 12 at 8:36 PM
$COCP reload zone down here as pre market gave that chance to make 100%+ but now it's going to billions in cap after phase 1b and 2a in 6 months or less like $WGS or $CDTX
1 · Reply
resurrect_momo21
resurrect_momo21 Sep. 12 at 5:13 PM
$COCP $WGS this clown @Resurrected_Magic used to be the #1 bash frost lover check is old account and new one what a real psych-O 🤡 who got wiped out 5 yrs ago @the_original_magic removed for fraud by ST @Resurrected_Magic
0 · Reply
MaverikIT
MaverikIT Sep. 11 at 10:22 PM
$WGS - trash they saying 🤣🤣🤣 $NUTX
0 · Reply
DARKP00L
DARKP00L Sep. 11 at 2:11 PM
$WGS 10:07 on Sep. 11 2025 Piper Sandler Maintains Overweight on GeneDx Holdings, Raises Price Target to $140 #tradeideas
0 · Reply
JarvisFlow
JarvisFlow Sep. 11 at 2:08 PM
Piper Sandler updates rating for GeneDx Holdings ( $WGS ) to Overweight, target set at 120 → 140.
0 · Reply
dogDazeSummer
dogDazeSummer Sep. 9 at 2:43 PM
Only 5 new adds for RA in latest Q: $HNGE $JBIO $TNGX $WGS and a “pipeline in pill” company from Germany, forgot the name. Total holdings are 63 many making ATH today. Interesting focus on immune dermatology. Here’s how much cash he dropped into each new starter position: Might want to follow these 5 names. $15M into Hinge $9.9m into Jade $7.3m into Omada $5.4m into GeneDx $3.2k into Inflarx
1 · Reply
Halo202
Halo202 Sep. 8 at 9:32 PM
$WGS $132+ by Friday
0 · Reply
Fujitsu99
Fujitsu99 Sep. 8 at 7:25 PM
$WGS Didn’t pull back like I thought it might. Just sideways, which is what we want. Didn’t sell a single share.
0 · Reply
resurrect_momo21
resurrect_momo21 Sep. 7 at 4:08 PM
$COCP $WGS "aka john jones" obvs got wiped out in mkt big time still calls everything a "scam" get this 🤡called GeneDx a fraud for yrs BUT reality smacks him in the fake "black face" 😂 $1.50 - $132+++ 20 mill to $4 billion in mkt cap. Same thing he says about cocrystal but just watch what happens on this one too biscayne boys 4ever❤️!! @the_original_magic 8200 meltdown bash posts @Resurrected_Magic 5600 bash posts
0 · Reply
CarverX
CarverX Sep. 5 at 7:45 PM
$WGS 🚀🚀🚀
0 · Reply
CarverX
CarverX Sep. 4 at 11:46 PM
$WGS 🚀🚀🚀
0 · Reply
CrayP
CrayP Sep. 4 at 3:25 PM
$WGS I guess Freedom Capital doesn't have the same clout that it used to..
0 · Reply
FinJay
FinJay Aug. 31 at 8:11 PM
$WGS https://youtu.be/k4eKzFEcpto
0 · Reply
Fujitsu99
Fujitsu99 Aug. 30 at 1:26 AM
$WGS im bullish but todays candle looks toppy as fuck
0 · Reply
ProfXtreme
ProfXtreme Aug. 29 at 8:34 PM
$WGS Beautiful Ascending triangle daily chart taking place after the start of a 3 year cup and handle breakout. Ascending triangle also looks like the middle 2 bar rest of a 3 bar play when viewing weekly chart breakout with no resistance to the left. Of course, it will fall back below $100 instead of going higher next week now that I jynxed it. Any technical trader opinions?
0 · Reply
CarverX
CarverX Aug. 29 at 3:30 PM
$WGS 🚀🚀🚀😎
0 · Reply
Meffjenkins
Meffjenkins Aug. 27 at 11:30 PM
$WGS great company
0 · Reply
CarverX
CarverX Aug. 27 at 5:42 PM
$WGS The force is strong with this one 🚀🚀🚀
0 · Reply
CarverX
CarverX Aug. 26 at 8:01 PM
$WGS Higher lows and higher highs. Upward sloping 20 day 50 day and 200 day EMA. Price at Upper part of Bollinger band 🚀🚀🚀
0 · Reply
HypnoTrader
HypnoTrader Aug. 25 at 2:01 AM
$TLS by way of example, $WGS, insiders started selling 14 months ago at about $24 and are continuing to sell now in low $100S. In my experience, insider buys, same as insider sells are a strong signal of nothing....
0 · Reply
Halo202
Halo202 Aug. 24 at 11:30 PM
$WGS $135+ this week
0 · Reply